Altogether, it was concluded that MBZ suppresses cancer progression through inhibition of the Notch1 signaling pathway, and Notch1 could be a critical target in T-ALL (Figure 4F). The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.